Tristel Achieves Strong Financial Growth
Company Announcements

Tristel Achieves Strong Financial Growth

Tristel (GB:TSTL) has released an update.

Tristel plc has reported a robust financial performance for the fiscal year ending June 30, 2024, with revenues soaring by 16.4% to £41.9 million and pre-tax profits climbing to at least £8.0 million, surpassing both market and internal expectations. The company, specializing in infection prevention products, remains debt-free and has strengthened its cash position, while expanding into North American markets with FDA and Health Canada approvals. As the CEO transitions, Tristel is poised to leverage its niche in medical device decontamination and expand into hospital surface disinfection.

For further insights into GB:TSTL stock, check out TipRanks’ Stock Analysis page.

Related Articles
Austin AngeloTristel (TSTL) Announces Q4 Dividend: Read On for Important Dates
TipRanks UK Auto-Generated NewsdeskTristel PLC Achieves Record Growth in 2024
TipRanks UK Auto-Generated NewsdeskTristel PLC Announces Upcoming Financial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App